Alcami Carolinas Corporation

Wilmington, NC

UEI
D2DHUF4NTK23
CAGE
0QK01, 5M9U8
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2320 Scientific Park Dr, Wilmington, NC 28405, USA
Website
alcami.com
Founded
1979
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Human Resource & Employment Services
SIC code
73 Business Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $60,005
FY2025 $0
FY2024 $0
FY2023 $15,236

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $60,005

Contract awards

Similar vendors

About the company

Alcami Carolinas Corporation, doing business as Alcami Corporation, is a for-profit manufacturer of goods headquartered in Wilmington, North Carolina. The company is registered in SAM.gov and maintains an active federal vendor status with registration set to expire on December 29, 2026. Alcami Corporation specializes in providing specialized testing and stability services to federal agencies, particularly within the pharmaceutical and life sciences sectors, supporting regulatory compliance and product development initiatives across multiple components of the federal government.

Alcami Carolinas Corporation has demonstrated substantial expertise in pharmaceutical stability testing and analytical laboratory services through its federal contract portfolio. Most recently, the company was awarded a $60,005 firm fixed-price purchase order by the National Human Genome Research Institute in December 2025 to conduct stability testing services on ManNAc drug product, with work performance extending through December 9, 2026. Prior to this, the company completed a $85,652 purchase order contract with the National Institute on Drug Abuse, awarded in August 2022, for a capsule and placebo stability program supporting research on ghrelin signaling manipulation in alcohol use disorder testing. Additionally, Alcami Carolinas Corporation served as a subcontractor to Battelle Memorial Institute on a federal contract awarded in January 2021, providing scopolamine storage and stability services. Across these awards, the company has demonstrated capabilities in regulatory-compliant pharmaceutical testing, stability analysis, and analytical support services that align with federal agency needs in drug development, genomics research, and substance abuse research initiatives.

Quick answers

Is Alcami Carolinas Corporation registered in SAM.gov?

Yes. Alcami Carolinas Corporation's SAM.gov registration is active through August 3, 2027.

What are Alcami Carolinas Corporation's CAGE codes?

Alcami Carolinas Corporation has 2 CAGE codes: 0QK01 and 5M9U8. Its Unique Entity ID (UEI) is D2DHUF4NTK23.

How much has Alcami Carolinas Corporation received in federal contracts?

Federal contracts obligated $75,241 to Alcami Carolinas Corporation in fiscal years 2023 through 2027.

What is Alcami Carolinas Corporation's most recent federal award?

Alcami Carolinas Corporation's most recent federal contract award is Alcami carolinas corporation:1360236 [26-000076] (75N92026P00018), from National Heart Lung and Blood Institute (NIH), on December 10, 2025.

On GovTribe

See Alcami Carolinas Corporation's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe